Clin2
NCT07309029Possibly a fitRecruiting

ECMO support during high-risk TAVR heart valve procedure

Severe Aortic StenosisCardiogenic ShockCardiogenic Shock, ECMOTrans-catheter Aortic Valve Implantation

Part of Heart & circulation clinical trials.

This trial tests whether placing patients on ECMO (a heart-lung support machine) before a high-risk TAVR valve replacement can improve safety and outcomes. It is for people who are at very high risk due to low blood pressure, severe heart or lung problems, or complex valve anatomy.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years to 100 years
Study type
Observational

Who can take part

  • You must be 18 years or older and not pregnant.
  • You need to have either severely low blood pressure or signs of shock, OR you have complex heart anatomy that makes the valve procedure risky.
  • You must not have severe blockages in leg arteries that prevent ECMO use.
  • You must not have had a cardiac arrest that required CPR for over 40 minutes.
  • This trial is not for people who are stable or have simple valve anatomy with low risk.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06638268Recruiting
TAVI for severe aortic stenosis in cardiogenic shock

This study tests whether a procedure called TAVI (a valve replacement done through a tube in the leg) can help people with severe aortic stenosis who are in cardiogenic shock, a dangerous condition where the heart can't pump enough blood. The goal is to see if urgent valve replacement improves survival.

Copenhagen O
NCT06818006Not yet recruiting· Phase 4
TAVI at centers without on-site heart surgery

This study tests whether TAVI (a procedure to replace your heart valve without open-heart surgery) can be done safely at centers that do not have on-site heart surgery backup. It looks at how well patients do after the procedure, focusing on safety and recovery.

Edmonton, Alberta
NCT04893603Recruiting
TAVR valve test for severe, hard-to-pump heart valve

This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.

Beijing
NCT07053618Recruiting
Heart pump support for high-risk heart procedures

This trial tests a temporary heart pump to support patients with weak hearts (ejection fraction 35% or less) who need a high-risk stent procedure instead of bypass surgery. The pump may help keep blood flowing during the procedure.

Beijing, Beijing Municipality
NCT07108478Not yet recruiting
Emergency valve replacement for severe aortic stenosis

This study looks at how safe and effective emergency aortic valve replacement is for people with severe aortic stenosis, a condition where the heart's main valve becomes narrow. It aims to help patients who are in critical condition, such as those in shock or with dangerous heart rhythms, by replacing the valve urgently.

Jinan, Shandong
NCT07030062Recruiting
Echo-guided aortic valve replacement (Echo TAVR)

This trial tests a way to replace your aortic valve using only ultrasound (echo) instead of X-rays or dye. It may be a good fit if you have severe aortic stenosis and need to avoid contrast or radiation because of kidney problems or cancer risk.

Beijing

Hear when a new Severe Aortic Stenosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.